Page last updated: 2024-10-31

methylphenidate and Disruptive, Impulse Control, and Conduct Disorders

methylphenidate has been researched along with Disruptive, Impulse Control, and Conduct Disorders in 12 studies

Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.

Disruptive, Impulse Control, and Conduct Disorders: Disorders whose essential features are the failure to resist an impulse, drive, or temptation to perform an act that is harmful to the individual or to others. Individuals experience an increased sense of tension prior to the act and pleasure, gratification or release of tension at the time of committing the act.

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (8.33)18.2507
2000's7 (58.33)29.6817
2010's4 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Naguy, A1
Abdelhakim, W1
Al-Tajali, A1
Yılmaz, S1
Bilgiç, A1
Spada, MM1
Hergüner, S1
Tanidir, C1
Neef, NA1
Bicard, DF1
Endo, S1
Coury, DL1
Aman, MG1
Blondeau, C1
Dellu-Hagedorn, F1
Huang, YS1
Guilleminault, C1
Li, HY1
Yang, CM1
Wu, YY1
Chen, NH1
Chamberlain, SR1
Robbins, TW1
Sahakian, BJ1
Murphy, K1
Ramsay, JR1
Rostain, AL1
Mattos, P1
Feeney, DJ1
Klykylo, WM1
Binder, LM1
Dixon, MR1
Ghezzi, PM1
Adrian, N1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Validation of Sleep Questionnaires in the Down Syndrome Population[NCT03771469]81 participants (Actual)Interventional2018-06-25Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for methylphenidate and Disruptive, Impulse Control, and Conduct Disorders

ArticleYear
An overview of problematic internet use.
    Addictive behaviors, 2014, Volume: 39, Issue:1

    Topics: Antidepressive Agents, Second-Generation; Behavior, Addictive; Central Nervous System Stimulants; Ci

2014

Trials

1 trial available for methylphenidate and Disruptive, Impulse Control, and Conduct Disorders

ArticleYear
Evaluation of pharmacological treatment of impulsivity in children with attention deficit hyperactivity disorder.
    Journal of applied behavior analysis, 2005,Summer, Volume: 38, Issue:2

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child;

2005

Other Studies

10 other studies available for methylphenidate and Disruptive, Impulse Control, and Conduct Disorders

ArticleYear
Two Adolescent Cases of Psychotropic-Related Nonaffective Oniomania.
    Journal of child and adolescent psychopharmacology, 2018, Volume: 28, Issue:4

    Topics: Adolescent; Aripiprazole; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Methyl

2018
The possible effect of methylphenidate on kleptomania in a school-age girl with attention-deficit/hyperactivity disorder.
    European child & adolescent psychiatry, 2014, Volume: 23, Issue:5

    Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Disruptive,

2014
An adolescent with kleptomania and attention-deficit/hyperactivity disorder treated with methylphenidate.
    Journal of child and adolescent psychopharmacology, 2011, Volume: 21, Issue:4

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Comorb

2011
Dimensional analysis of ADHD subtypes in rats.
    Biological psychiatry, 2007, Jun-15, Volume: 61, Issue:12

    Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hy

2007
Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
    Sleep medicine, 2007, Volume: 8, Issue:1

    Topics: Adenoidectomy; Adenoids; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimu

2007
The neurobiology of attention-deficit/hyperactivity disorder.
    Biological psychiatry, 2007, Jun-15, Volume: 61, Issue:12

    Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivi

2007
Treatment strategies for a case of severe ADHD.
    Journal of attention disorders, 2007, Volume: 11, Issue:3

    Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cognitive B

2007
Treatment for kleptomania.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1997, Volume: 36, Issue:6

    Topics: 1-Naphthylamine; Antidepressive Agents; Central Nervous System Stimulants; Child; Disruptive, Impuls

1997
A procedure to teach self-control to children with attention deficit hyperactivity disorder.
    Journal of applied behavior analysis, 2000,Summer, Volume: 33, Issue:2

    Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child, Preschool;

2000
Explosive outbursts associated with methylphenidate.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2001, Volume: 40, Issue:6

    Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Pres

2001